NCT02520687

Brief Summary

High blood pressure in pregnancy affects around 10% of pregnancies, and is associated with serious adverse outcomes for both mother and baby. Treatment options for the management of high blood pressure in pregnancy are currently limited. Studies in non-pregnant individuals have shown that supplementation with dietary nitrate, using beetroot juice, can significantly lower blood pressure and improve blood flow. This study aims to investigate whether supplementation with dietary nitrate (via beetroot juice) can improve blood pressure regulation in pregnant women with chronic high blood pressure, and will also determine whether this can improve blood flow across the placenta.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 13, 2015

Completed
19 days until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

1.4 years

First QC Date

August 5, 2015

Last Update Submit

April 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in clinic blood pressure (compared to baseline) between treatment and placebo groups

    The outcome will be determined after 7 days treatment (compared to baseline)

Secondary Outcomes (5)

  • Recruitment rates

    Across study (18 months)

  • Uterine artery blood flow (compared to baseline)

    The outcome will be determined after 7 days treatment (compared to baseline)

  • Umbilical artery blood flow (compared to baseline)

    The outcome will be determined after 7 days treatment (compared to baseline)

  • Changes in plasma and salivary nitrate concentrations

    The outcome will be determined after 7 days treatment (compared to baseline)

  • Changes in plasma and salivary nitrite concentrations

    The outcome will be determined after 7 days treatment (compared to baseline)

Study Arms (2)

Dietary nitrate, beetroot juice

EXPERIMENTAL

Once daily 70mL dose of beetroot juice, containing 400mg inorganic nitrate, for 7 consecutive days.

Dietary Supplement: Beetroot juice

Nitrate-depleted beetroot juice

PLACEBO COMPARATOR

Once daily 70mL dose of beetroot juice, depleted of nitrate, for 7 consecutive days.

Dietary Supplement: Nitrate-depleted beetroot juice

Interventions

Beetroot juiceDIETARY_SUPPLEMENT

70mls daily for seven days

Dietary nitrate, beetroot juice

70mls daily for seven days

Nitrate-depleted beetroot juice

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women diagnosed with chronic hypertension (systolic blood pressure of 130-144 mmHg and/or diastolic blood pressure of 80-94 mmHg).
  • Between 22 - 35+6 weeks gestation

You may not qualify if:

  • Multi-fetal pregnancy
  • Currently taking anti-hypertensive medication
  • Pre-existing diabetes (Type 1 or Type 2)
  • Lacking ability to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternal and Fetal Health Research Centre

Manchester, M13 9WL, United Kingdom

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Dietary Nitrate
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

August 5, 2015

First Posted

August 13, 2015

Study Start

September 1, 2015

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

April 15, 2025

Record last verified: 2025-04

Locations